High LDL causes: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(25 intermediate revisions by 3 users not shown)
Line 4: Line 4:


==Overview==
==Overview==
High LDL can be primary or secondary to [[Saturated fat|diet high in saturated fat]], [[hypothyroidism]], [[nephrotic syndrome]], [[pregnancy]], [[obesity]], or medications such as [[amiodarone]], [[cyclosporine]], [[diuretics]], and [[glucocorticoids]].<ref name="pmid24239923">{{cite journal| author=Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH et al.| title=2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. | journal=J Am Coll Cardiol | year= 2014 | volume= 63 | issue= 25 Pt B | pages= 2889-934 | pmid=24239923 | doi=10.1016/j.jacc.2013.11.002 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24239923  }} </ref>  High LDL can also be caused by [[inherited]] diseases that affect the [[lipid metabolism]].


==Causes==
==Causes==
Line 9: Line 10:
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.


High LDL does not have any life-threatening cause.


===Common Causes===
===Common Causes===
 
* [[Amiodarone]]
* [[Anorexia]]
* [[Biliary obstruction]]
* [[Cyclosporine]]
* [[Diuretics]]
*[[Familial hypercholesterolemia]]<ref name="Durrington-2003">{{Cite journal  | last1 = Durrington | first1 = P. | title = Dyslipidaemia. | journal = Lancet | volume = 362 | issue = 9385 | pages = 717-31 | month = Aug | year = 2003 | doi = 10.1016/S0140-6736(03)14234-1 | PMID = 12957096 }}</ref>
* [[Glucocorticoids]]
*[[Saturated fat|High saturated fat diet]]<ref name="Covington-2004">{{Cite journal  | last1 = Covington | first1 = MB. | title = Omega-3 fatty acids. | journal = Am Fam Physician | volume = 70 | issue = 1 | pages = 133-40 | month = Jul | year = 2004 | doi =  | PMID = 15259529 }}</ref>
* [[Hypothyroidism]]
* [[Nephrotic syndrome]]
* [[Obesity]]
* [[Pregnancy]]
* [[Weight gain]]<ref name="pmid24239923">{{cite journal| author=Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH et al.| title=2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. | journal=J Am Coll Cardiol | year= 2014 | volume= 63 | issue= 25 Pt B | pages= 2889-934 | pmid=24239923 | doi=10.1016/j.jacc.2013.11.002 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24239923  }} </ref>


===Causes by Organ System===
===Causes by Organ System===
Line 20: Line 34:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Chemical/Poisoning'''
| '''Chemical/Poisoning'''
|bgcolor="Beige"| [[Diterpenoids]]
|bgcolor="Beige"| [[Terpenoid|Diterpenoids]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 32: Line 46:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Drug Side Effect'''
| '''Drug Side Effect'''
|bgcolor="Beige"| [[Atazanavir]],  [[azathioprine]],  [[bexarotene]],  [[Immunosuppressive drug#Drugs acting on immunophilins|calcineurin inhibitors]],  [[chlortalidone]],  [[corticosteroids]],  [[cyclosporine]], [[desvenlafaxine]], [[Fish oil|fish oil supplements]], [[immunosuppressive agents]],  [[levonorgestrel]],  [[lopinavir]],  [[mycophenolate]],  [[nicotine]],  [[norgestrel]],  [[prednisone]],  [[progestin]],  [[rapamycin]],  [[rosiglitazone]],  [[sirolimus]],  [[thiazide]],  [[tocilizumab]]
|bgcolor="Beige"| [[Amiodarone]], [[atazanavir]],  [[azathioprine]],  [[bexarotene]],  [[Immunosuppressive drug#Drugs acting on immunophilins|calcineurin inhibitors]],  [[chlortalidone]],  [[corticosteroids]],  [[cyclosporine]], [[Dapagliflozin]], [[Danazol]], [[desvenlafaxine]], [[diuretics]], [[Fish oil|fish oil supplements]], [[glucocorticoid]], [[immunosuppressive agents]],  [[levonorgestrel]],  [[lopinavir]],  [[Medroxyprogesterone acetate]], [[mycophenolate]],  [[nicotine]],  [[norgestrel]], [[Norgestrel and Ethinyl estradiol]],  [[prednisone]],  [[progestin]],  [[rapamycin]],  [[rosiglitazone]],  [[sirolimus]],  [[thiazide]],  [[tocilizumab]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 48: Line 62:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Gastroenterologic'''
| '''Gastroenterologic'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"| [[Biliary obstruction]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Genetic'''
| '''Genetic'''
|bgcolor="Beige"| [[Niemann-Pick disease|Acid sphingomyelinase deficiency]],  [[Familial hypercholesterolemia|autosomal recessive hypercholesterolemia]],  [[familial combined hyperlipidemia]],  [[Apolipoprotein B deficiency|familial defective apolipoprotein B-100]],  [[familial hypercholesterolemia]],  [[hyperapobetalipoproteinemia]],  [[IL 28B polymorphisms]],  [[Niemann-Pick disease]],  [[hypercholesterolemia|polygenic hypercholesterolemia]]  
|bgcolor="Beige"| [[Niemann-Pick disease|Acid sphingomyelinase deficiency]],  [[Familial hypercholesterolemia|autosomal recessive hypercholesterolemia]],  [[familial combined hyperlipidemia]],  [[Apolipoprotein B deficiency|familial defective apolipoprotein B-100]],  [[familial hypercholesterolemia]],  [[Interleukin 28#Clinical Significance|IL 28B polymorphisms]],  [[Niemann-Pick disease]],  [[hypercholesterolemia|polygenic hypercholesterolemia]]  
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 64: Line 78:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Infectious Disease'''
| '''Infectious Disease'''
|bgcolor="Beige"| [[Gram negative bacteremia]],  [[H. pylori]],  [[small bowel bacterial overgrowth syndrome]],
|bgcolor="Beige"| [[Gram negative bacteremia]],  [[H. pylori]],  [[small bowel bacterial overgrowth syndrome]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 80: Line 94:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Obstetric/Gynecologic'''
| '''Obstetric/Gynecologic'''
|bgcolor="Beige"| [[Polycystic ovarian syndrome]]
|bgcolor="Beige"| [[Polycystic ovarian syndrome]], [[pregnancy]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 124: Line 138:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Miscellaneous'''
| '''Miscellaneous'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"| [[Anorexia]], [[obesity]], [[weight gain]]
|-
|-
|}
|}
Line 132: Line 146:
{{col-break|width=33%}}
{{col-break|width=33%}}
*[[Niemann-Pick disease|Acid sphingomyelinase deficiency]]
*[[Niemann-Pick disease|Acid sphingomyelinase deficiency]]
* [[Amiodarone]]
*[[Androgens]]
*[[Androgens]]
* [[Anorexia]]
*[[Atazanavir]]
*[[Atazanavir]]
*[[Familial hypercholesterolemia|Autosomal recessive hypercholesterolemia]]
*[[Familial hypercholesterolemia|Autosomal recessive hypercholesterolemia]]
*[[Azathioprine]]
*[[Azathioprine]]
*[[Bexarotene]]
*[[Bexarotene]]
* [[Biliary obstruction]]
*[[Immunosuppressive drug#Drugs acting on immunophilins|Calcineurin inhibitors]]
*[[Immunosuppressive drug#Drugs acting on immunophilins|Calcineurin inhibitors]]
*[[Chenodeoxycholic acid]]
*[[Chenodeoxycholic acid]]
Line 147: Line 164:
*[[Dehydroepiandrosterone]]
*[[Dehydroepiandrosterone]]
*[[Desvenlafaxine]]
*[[Desvenlafaxine]]
*[[Diterpenoids]]
*[[Terpenoid|Diterpenoids]]
* [[Diuretics]]
*[[Dysproteinemia]]
*[[Dysproteinemia]]
*[[Familial combined hyperlipidemia]]
*[[Familial combined hyperlipidemia]]
*[[Apolipoprotein B deficiency|Familial defective apolipoprotein B-100]]
*[[Apolipoprotein B deficiency|Familial defective apolipoprotein B-100]]
*[[Familial hypercholesterolemia]]
{{col-break|width=33%}}
{{col-break|width=33%}}
*[[Fish oil|Fish oil supplements]]
*[[Familial hypercholesterolemia]]<ref name="Durrington-2003">{{Cite journal  | last1 = Durrington | first1 = P. | title = Dyslipidaemia. | journal = Lancet | volume = 362 | issue = 9385 | pages = 717-31 | month = Aug | year = 2003 | doi = 10.1016/S0140-6736(03)14234-1 | PMID = 12957096 }}</ref>
*[[Fish oil|Fish oil supplements]]<ref name="Pejic-">{{Cite journal  | last1 = Pejic | first1 = RN. | last2 = Lee | first2 = DT. | title = Hypertriglyceridemia. | journal = J Am Board Fam Med | volume = 19 | issue = 3 | pages = 310-6 | month =  | year =  | doi =  | PMID = 16672684 }}</ref>
* [[Glucocorticoid]]
*[[Gram negative bacteremia]]
*[[Gram negative bacteremia]]
*[[Growth hormone deficiency]]
*[[Growth hormone deficiency]]
*[[H. pylori]]
*[[H. pylori]]
*[[Carbohydrate#Nutrition|High carbohydrate diet]]
*[[Carbohydrate#Nutrition|High carbohydrate diet]]
*[[High saturated fat diet]]
*[[Saturated fat|High saturated fat diet]]<ref name="Covington-2004">{{Cite journal  | last1 = Covington | first1 = MB. | title = Omega-3 fatty acids. | journal = Am Fam Physician | volume = 70 | issue = 1 | pages = 133-40 | month = Jul | year = 2004 | doi =  | PMID = 15259529 }}</ref>
*[[Hyperapobetalipoproteinemia]]
*[[Hypercortisolism]]
*[[Hypercortisolism]]
*[[Hypothyroidism]]
*[[Hypothyroidism]]
*[[IL 28B polymorphisms]]
*[[Interleukin 28#Clinical Significance|IL 28B polymorphisms]]
*[[Immunosuppressive agents]]
*[[Immunosuppressive agents]]
*[[LDL receptor deficiency]]
*[[LDL receptor deficiency]]
Line 170: Line 188:
*[[Monoclonal gammopathy]]
*[[Monoclonal gammopathy]]
*[[Mycophenolate]]
*[[Mycophenolate]]
*[[Nephrotic syndrome]]
*[[Nephrotic syndrome]]<ref name="Kronenberg-2005">{{Cite journal  | last1 = Kronenberg | first1 = F. | title = Dyslipidemia and nephrotic syndrome: recent advances. | journal = J Ren Nutr | volume = 15 | issue = 2 | pages = 195-203 | month = Apr | year = 2005 | doi =  | PMID = 15827892 }}</ref>
*[[Nicotine]]
*[[Nicotine]]
*[[Niemann-Pick disease]]
*[[Niemann-Pick disease]]
*[[Norgestrel]]
*[[Norgestrel]]
*[[Norgestrel and Ethinyl estradiol]]
* [[Obesity]]
*[[Xanthomatous biliary cirrhosis|Obstructive liver disease]]
{{col-break|width=33%}}
{{col-break|width=33%}}
*[[Obstructive liver disease]]
*[[Omega-3 fatty acid|Omega-3 polyunsaturated fatty acids]]
*[[Omega-3 fatty acid|Omega-3 polyunsaturated fatty acids]]
*[[Pancreatitis]]
*[[Pancreatitis]]
*[[Paraproteinemia]]
*[[Paraproteinemia]]
*[[Polycystic ovarian syndrome]]
*[[Polycystic ovarian syndrome]]
* [[Pregnancy]]
*[[Hypercholesterolemia|Polygenic hypercholesterolemia]]
*[[Hypercholesterolemia|Polygenic hypercholesterolemia]]
*[[Prednisone]]
*[[Prednisone]]
Line 196: Line 217:
*[[Thiazide]]
*[[Thiazide]]
*[[Tocilizumab]]
*[[Tocilizumab]]
* [[Weight gain]]
{{col-end}}
{{col-end}}


Latest revision as of 21:44, 16 January 2015

Low Density Lipoprotein Microchapters

Home

Patient information

Overview

Historical Perspective

Classification

Physiology

Pathophysiology

Causes

Low LDL
High LDL

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Prognosis and Complications

Diagnosis

Laboratory Findings

Treatment

Medical Therapy

Landmark Trials

Future or Investigational Therapies

Case Studies

Case #1

High LDL causes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of High LDL causes

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on High LDL causes

CDC on High LDL causes

High LDL causes in the news

Blogs on High LDL causes

Directions to Hospitals Treating Low density lipoprotein

Risk calculators and risk factors for High LDL causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Rim Halaby, M.D. [3]; Vendhan Ramanujam M.B.B.S [4]

Overview

High LDL can be primary or secondary to diet high in saturated fat, hypothyroidism, nephrotic syndrome, pregnancy, obesity, or medications such as amiodarone, cyclosporine, diuretics, and glucocorticoids.[1] High LDL can also be caused by inherited diseases that affect the lipid metabolism.

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.

High LDL does not have any life-threatening cause.

Common Causes

Causes by Organ System

Cardiovascular No underlying causes
Chemical/Poisoning Diterpenoids
Dental No underlying causes
Dermatologic No underlying causes
Drug Side Effect Amiodarone, atazanavir, azathioprine, bexarotene, calcineurin inhibitors, chlortalidone, corticosteroids, cyclosporine, Dapagliflozin, Danazol, desvenlafaxine, diuretics, fish oil supplements, glucocorticoid, immunosuppressive agents, levonorgestrel, lopinavir, Medroxyprogesterone acetate, mycophenolate, nicotine, norgestrel, Norgestrel and Ethinyl estradiol, prednisone, progestin, rapamycin, rosiglitazone, sirolimus, thiazide, tocilizumab
Ear Nose Throat No underlying causes
Endocrine Androgens, dehydroepiandrosterone, growth hormone deficiency, hypercortisolism, hypothyroidism, polycystic ovarian syndrome, progestagens, subclinical hypothyroidism, testosterone
Environmental No underlying causes
Gastroenterologic Biliary obstruction
Genetic Acid sphingomyelinase deficiency, autosomal recessive hypercholesterolemia, familial combined hyperlipidemia, familial defective apolipoprotein B-100, familial hypercholesterolemia, IL 28B polymorphisms, Niemann-Pick disease, polygenic hypercholesterolemia
Hematologic No underlying causes
Iatrogenic No underlying causes
Infectious Disease Gram negative bacteremia, H. pylori, small bowel bacterial overgrowth syndrome
Musculoskeletal/Orthopedic No underlying causes
Neurologic No underlying causes
Nutritional/Metabolic Chenodeoxycholic acid, high carbohydrate diet, high saturated fat diet, omega-3 polyunsaturated fatty acids, polygenic hypercholesterolemia, primary hyperlipoproteinemia, primary hypolipoproteinemia, selenium deficiency
Obstetric/Gynecologic Polycystic ovarian syndrome, pregnancy
Oncologic No underlying causes
Ophthalmologic No underlying causes
Overdose/Toxicity No underlying causes
Psychiatric No underlying causes
Pulmonary No underlying causes
Renal/Electrolyte Chronic kidney disease, nephrotic syndrome
Rheumatology/Immunology/Allergy Dysproteinemia, lipopolysaccharides, monoclonal gammopathy, paraproteinemia
Sexual No underlying causes
Trauma No underlying causes
Urologic No underlying causes
Miscellaneous Anorexia, obesity, weight gain

Causes in Alphabetical Order

References

  1. ↑ 1.0 1.1 Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH; et al. (2014). "2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". J Am Coll Cardiol. 63 (25 Pt B): 2889–934. doi:10.1016/j.jacc.2013.11.002. PMID 24239923.
  2. ↑ 2.0 2.1 Durrington, P. (2003). "Dyslipidaemia". Lancet. 362 (9385): 717–31. doi:10.1016/S0140-6736(03)14234-1. PMID 12957096. Unknown parameter |month= ignored (help)
  3. ↑ 3.0 3.1 Covington, MB. (2004). "Omega-3 fatty acids". Am Fam Physician. 70 (1): 133–40. PMID 15259529. Unknown parameter |month= ignored (help)
  4. ↑ Pejic, RN.; Lee, DT. "Hypertriglyceridemia". J Am Board Fam Med. 19 (3): 310–6. PMID 16672684.
  5. ↑ Kronenberg, F. (2005). "Dyslipidemia and nephrotic syndrome: recent advances". J Ren Nutr. 15 (2): 195–203. PMID 15827892. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=High_LDL_causes&oldid=1056113"